
    
      A randomized, double blind, multicenter phase3 study in chemotherapy naive patients with
      stage IIIB,IV or recurrent NSCLC of non-squamous. the study will randomize about 436 patients
      at a 1:1 ratio to 2 treatment arms. The study is divided 4 phase, screening, combination
      treatment, maintenance and follow up.
    
  